Year 2020,
Volume: 9 Issue: 3, 139 - 141, 21.12.2020
Hatice Tuba Akbayram
,
Ayse Ören
References
- 1. Starkey E, Shahidullah H. Propranolol for infantile haemangiomas: a review. Arch Dis Child 2011; 96(9): 890-93.
- 2. Yang H, Hu DL, Shu Q, Guo XD. Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies. World J Pediatr 2019; 15: 546–58.
- 3. Kim J, Hong JW, Roh TS, Lee WJ. Oral propranolol therapy in 23 infants with infantile hemangioma. Arch Plast Surg 2018;45(6): 517-24.
- 4. Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017; 390 (10089): 85–94.
- 5. Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: A systematic review. Lasers Surg Med. 2016; 48(3): 221–33.
- 6. Ng M, Knuth C, Weisbrod C, Murthy A. Propranolol therapy for problematic infantile hemangioma. Ann Plast Surg 2016; 76 (3): 306-10.
- 7. Wang C, Li Y, Xiang B, Xiong F, Li K, Yang K, Chen S, Ji Y. Quality of life in children with infantile hemangioma: a case control study. Health Qual Life Outcomes 2017; 15(1): 221.
- 8. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
- 9. Greenberger S, Bischoff J. Pathogenesis of infantile haemangioma. Brit J Dermatol 2013; 169: 12-9.
- 10. Aslan N, Arıkan E, Sivrice C, Ayata A. Propranolol ile Tedavi Edilen İnfantil Hemanjiyom: Bir Olgu Sunumu. Türkiye Çocuk Hast Derg 2015; 4: 278-279.
İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu
Year 2020,
Volume: 9 Issue: 3, 139 - 141, 21.12.2020
Hatice Tuba Akbayram
,
Ayse Ören
Abstract
İnfantil hemanjiom bebeklik döneminin en sık görülen vasküler selim tümörüdür. İnfantil hemanjiomun tedavisinde steroidler yıllardır ilk tercih olmakla birlikte son yıllarda oral propranolol de kullanılmaya başlanmıştır. Bu olgu ile eksremitelerinde hızlı büyüyen infantil hemanjiomu olan 1 aylık kız hastada birinci basamak tedavi olarak oral propranolol kullanımı sunulmuştur.
References
- 1. Starkey E, Shahidullah H. Propranolol for infantile haemangiomas: a review. Arch Dis Child 2011; 96(9): 890-93.
- 2. Yang H, Hu DL, Shu Q, Guo XD. Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies. World J Pediatr 2019; 15: 546–58.
- 3. Kim J, Hong JW, Roh TS, Lee WJ. Oral propranolol therapy in 23 infants with infantile hemangioma. Arch Plast Surg 2018;45(6): 517-24.
- 4. Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017; 390 (10089): 85–94.
- 5. Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: A systematic review. Lasers Surg Med. 2016; 48(3): 221–33.
- 6. Ng M, Knuth C, Weisbrod C, Murthy A. Propranolol therapy for problematic infantile hemangioma. Ann Plast Surg 2016; 76 (3): 306-10.
- 7. Wang C, Li Y, Xiang B, Xiong F, Li K, Yang K, Chen S, Ji Y. Quality of life in children with infantile hemangioma: a case control study. Health Qual Life Outcomes 2017; 15(1): 221.
- 8. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
- 9. Greenberger S, Bischoff J. Pathogenesis of infantile haemangioma. Brit J Dermatol 2013; 169: 12-9.
- 10. Aslan N, Arıkan E, Sivrice C, Ayata A. Propranolol ile Tedavi Edilen İnfantil Hemanjiyom: Bir Olgu Sunumu. Türkiye Çocuk Hast Derg 2015; 4: 278-279.